EP3151859

Áhrifarík og skilvirk stýring á sermifosfati fyrir æskilegustu beinmyndun

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    29.5.2015
  • EP published:
    25.11.2020
  • EP application number:
    15806501.1
  • Max expiry date:
    28.5.2035
  • Expiry date:
    28.5.2026
  • Next due date:
    31.5.2026
  • Title:
    THE EFFECTIVE AND EFFICIENT CONTROL OF SERUM PHOSPHATE FOR OPTIMAL BONE FORMATION

Timeline

Today
29.5.2015EP application
25.11.2020EP Publication
11.2.2021Translation submitted
15.3.2021Registration published
28.5.2026Expires

Owner

  • Name:
    Ultragenyx Pharmaceutical Inc.
  • Address:
    60 Leveroni Court, Novato, CA 94949, US
  • Name:
    Kyowa Kirin Co., Ltd.
  • Address:
    1-9-2, Otemachi, Chiyoda-ku,, Tokyo, 100-0004, JP

Inventor

  • Name:
    KAKKIS, Emil
  • Address:
    San Rafael, California 94901, US
  • Name:
    SAN MARTIN, Javier
  • Address:
    Novato, California 94949, US
  • Name:
    SUDO, Tomohiro
  • Address:
    Chiyoda-ku Tokyo 100-8185, JP

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    201462009474 P
  • Date:
    9.6.2014
  • Country:
    US

Classification

  • Categories:
    A61P 19/08, A61K 39/395, C07K 14/50, C07K 16/22, A61K 39/00

Annual fees

Number

Paid

Expires

Payer

Number: 7

Paid: 3.5.2021

Expires: 28.5.2022

Payer: Sigurjónsson & Thor ehf.

Number: 8

Paid: 3.5.2022

Expires: 28.5.2023

Payer: Patice ehf.

Number: 9

Paid: 25.5.2023

Expires: 28.5.2024

Payer: Maxval Group, Inc.

Number: 10

Paid: 17.5.2024

Expires: 28.5.2025

Payer: Maxval Group, Inc.

Number: 11

Paid: 16.4.2025

Expires: 28.5.2026

Payer: Maxval Group, Inc.

Upload documents